Hauptseite > Publikationsdatenbank > Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients > print |
001 | 1014969 | ||
005 | 20240311125732.0 | ||
024 | 7 | _ | |a 10.1016/j.clim.2023.109757 |2 doi |
024 | 7 | _ | |a 1521-6616 |2 ISSN |
024 | 7 | _ | |a 1521-7035 |2 ISSN |
024 | 7 | _ | |a 10.34734/FZJ-2023-03513 |2 datacite_doi |
024 | 7 | _ | |a 37689091 |2 pmid |
024 | 7 | _ | |a WOS:001165275000001 |2 WOS |
037 | _ | _ | |a FZJ-2023-03513 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Yakici, Nalan |0 P:(DE-HGF)0 |b 0 |
245 | _ | _ | |a Expanding the clinical and immunological phenotypes of PAX1-deficient SCID and CID patients |
260 | _ | _ | |a Orlando, Fla. |c 2023 |b Academic Press |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1695379413_3362 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Paired box 1 (PAX1) deficiency has been reported in a small number of patients diagnosed with otofaciocervical syndrome type 2 (OFCS2). We described six new patients who demonstrated variable clinical penetrance. Reduced transcriptional activity of pathogenic variants confirmed partial or complete PAX1 deficiency. Thymic aplasia and hypoplasia were associated with impaired T cell immunity. Corrective treatment was required in 4/6 patients. Hematopoietic stem cell transplantation resulted in poor immune reconstitution with absent naïve T cells, contrasting with the superior recovery of T cell immunity after thymus transplantation. Normal ex vivo differentiation of PAX1-deficient CD34+ cells into mature T cells demonstrated the absence of a hematopoietic cell-intrinsic defect. New overlapping features with DiGeorge syndrome included primary hypoparathyroidism (n = 5) and congenital heart defects (n = 2), in line with PAX1 expression during early embryogenesis. Our results highlight new features of PAX1 deficiency, which are relevant to improving early diagnosis and identifying patients requiring corrective treatment. |
536 | _ | _ | |a 5111 - Domain-Specific Simulation & Data Life Cycle Labs (SDLs) and Research Groups (POF4-511) |0 G:(DE-HGF)POF4-5111 |c POF4-511 |f POF IV |x 0 |
536 | _ | _ | |a 2171 - Biological and environmental resources for sustainable use (POF4-217) |0 G:(DE-HGF)POF4-2171 |c POF4-217 |f POF IV |x 1 |
536 | _ | _ | |a GRK 2158 - GRK 2158: Naturstoffe und Analoga gegen Therapie-resistente Tumoren und Mikroorganismen: Neue Leitstrukturen und Wirkmechanismen (270650915) |0 G:(GEPRIS)270650915 |c 270650915 |x 2 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
700 | 1 | _ | |a Kreins, Alexandra Y. |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Catak, Mehmet Cihangir |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Babayeva, Royala |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Erman, Baran |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Kenney, Heather |0 P:(DE-HGF)0 |b 5 |
700 | 1 | _ | |a Gungor, Hatice Eke |0 P:(DE-HGF)0 |b 6 |
700 | 1 | _ | |a Cea, Pablo A. |0 P:(DE-HGF)0 |b 7 |
700 | 1 | _ | |a Kawai, Tomoki |0 P:(DE-HGF)0 |b 8 |
700 | 1 | _ | |a Bosticardo, Marita |0 P:(DE-HGF)0 |b 9 |
700 | 1 | _ | |a Delmonte, Ottavia Maria |0 P:(DE-HGF)0 |b 10 |
700 | 1 | _ | |a Adams, Stuart |0 P:(DE-HGF)0 |b 11 |
700 | 1 | _ | |a Fan, Yu-Tong |0 P:(DE-HGF)0 |b 12 |
700 | 1 | _ | |a Pala, Francesca |0 P:(DE-HGF)0 |b 13 |
700 | 1 | _ | |a Turkyilmaz, Ayberk |0 P:(DE-HGF)0 |b 14 |
700 | 1 | _ | |a Howley, Evey |0 P:(DE-HGF)0 |b 15 |
700 | 1 | _ | |a Worth, Austen |0 P:(DE-HGF)0 |b 16 |
700 | 1 | _ | |a Kot, Hakan |0 P:(DE-HGF)0 |b 17 |
700 | 1 | _ | |a Sefer, Asena Pinar |0 P:(DE-HGF)0 |b 18 |
700 | 1 | _ | |a Kara, Altan |0 P:(DE-HGF)0 |b 19 |
700 | 1 | _ | |a Bulutoglu, Alper |0 P:(DE-HGF)0 |b 20 |
700 | 1 | _ | |a Eltan, Sevgi Bilgic |0 P:(DE-HGF)0 |b 21 |
700 | 1 | _ | |a Altunbas, Melek Yorgun |0 P:(DE-HGF)0 |b 22 |
700 | 1 | _ | |a Bayram, Feyza |0 P:(DE-HGF)0 |b 23 |
700 | 1 | _ | |a Karakus, Ibrahim Serhat |0 P:(DE-HGF)0 |b 24 |
700 | 1 | _ | |a Karatay, Emrah |0 P:(DE-HGF)0 |b 25 |
700 | 1 | _ | |a Tekeoglu, Sidem Didar |0 P:(DE-HGF)0 |b 26 |
700 | 1 | _ | |a Eser, Metin |0 P:(DE-HGF)0 |b 27 |
700 | 1 | _ | |a Albayrak, Davut |0 P:(DE-HGF)0 |b 28 |
700 | 1 | _ | |a Citli, Senol |0 P:(DE-HGF)0 |b 29 |
700 | 1 | _ | |a Kiykim, Ayca |0 P:(DE-HGF)0 |b 30 |
700 | 1 | _ | |a Karakoc-Aydiner, Elif |0 P:(DE-HGF)0 |b 31 |
700 | 1 | _ | |a Ozen, Ahmet |0 P:(DE-HGF)0 |b 32 |
700 | 1 | _ | |a Ghosh, Sujal |0 P:(DE-HGF)0 |b 33 |
700 | 1 | _ | |a Gohlke, Holger |0 P:(DE-Juel1)172663 |b 34 |u fzj |
700 | 1 | _ | |a Orhan, Fazil |0 P:(DE-HGF)0 |b 35 |
700 | 1 | _ | |a Notarangelo, Luigi D. |0 P:(DE-HGF)0 |b 36 |
700 | 1 | _ | |a Davies, E. Graham |0 P:(DE-HGF)0 |b 37 |
700 | 1 | _ | |a Baris, Safa |0 P:(DE-HGF)0 |b 38 |e Corresponding author |
773 | _ | _ | |a 10.1016/j.clim.2023.109757 |g p. 109757 - |0 PERI:(DE-600)1462862-4 |p 109757 |t Clinical immunology |v 255 |y 2023 |x 1521-6616 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/1014969/files/1-s2.0-S152166162300520X-main.pdf |y OpenAccess |
909 | C | O | |o oai:juser.fz-juelich.de:1014969 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 34 |6 P:(DE-Juel1)172663 |
913 | 1 | _ | |a DE-HGF |b Key Technologies |l Engineering Digital Futures – Supercomputing, Data Management and Information Security for Knowledge and Action |1 G:(DE-HGF)POF4-510 |0 G:(DE-HGF)POF4-511 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Enabling Computational- & Data-Intensive Science and Engineering |9 G:(DE-HGF)POF4-5111 |x 0 |
913 | 1 | _ | |a DE-HGF |b Forschungsbereich Erde und Umwelt |l Erde im Wandel – Unsere Zukunft nachhaltig gestalten |1 G:(DE-HGF)POF4-210 |0 G:(DE-HGF)POF4-217 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-200 |4 G:(DE-HGF)POF |v Für eine nachhaltige Bio-Ökonomie – von Ressourcen zu Produkten |9 G:(DE-HGF)POF4-2171 |x 1 |
914 | 1 | _ | |y 2023 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-03-30 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-03-30 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-03-30 |
915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-23 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-08-23 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CLIN IMMUNOL : 2022 |d 2023-08-23 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-23 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-23 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CLIN IMMUNOL : 2022 |d 2023-08-23 |
920 | _ | _ | |l yes |
920 | 1 | _ | |0 I:(DE-Juel1)IBG-4-20200403 |k IBG-4 |l Bioinformatik |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-Juel1)IBG-4-20200403 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|